跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hytrin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Hytrin
Approved
STANDARD
Hytrin
Aesica Queenborough Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1b45648c07a31dc1
Company
Aesica Queenborough Limited
Type
Standard
Approval Details
Approval Id
1b45648c07a31dc1
Drug Approval Philippines Name
Hytrin
Product Name
Hytrin
Registration Number
DRP-3678
Brand Name
Hytrin
Generic Name
Terazosin (as Hydrochloride)
Dosage Form
Tablet
Dosage Strength
2 mg
Manufacturer
Aesica Queenborough Limited
Importer
Abbott Laboratories
Distributor
Abbott Laboratories
Company Detail Path
/organization/aesica-queenborough-limited
Importer Detail Path
/organization/abbott-laboratories
Distributor Detail Path
/organization/abbott-laboratories
Issuance Date
08 July 2024
Expiry Date
11 August 2029
Pharmacologic Category
Alpha-Adrenoceptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1b45648c07a31dc1
Type
Standard
Back to Philippines FDA Approvals